β-arrestin-dependent actin reorganization: Bringing the right players together at the leading edge

Molecular Pharmacology

Volumn 80, Issue 5, 2011, Pages 760-768

  Min, Jungah ^a   DeFea, Kathryn ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; BETA ARRESTIN; GUANOSINE TRIPHOSPHATASE; MITOGEN ACTIVATED PROTEIN KINASE; TYROSINE;

CELL MIGRATION; HUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SHORT SURVEY;

ACTINS; ARRESTINS; CELL MOVEMENT; CYTOSKELETON; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 80054782210     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.111.072470     Document Type: Short Survey

References (68)

1. Anthony DF, Sin YY, Vadrevu S, Advant N, Day JP, Byrne AM, Lynch MJ, Milligan G, Houslay MD, and Baillie GS (2011) β-Arrestin 1 inhibits the GTPase-activating protein function of ARHGAP21, promoting activation of RhoA following angiotensin II type 1A receptor stimulation. Mol Cell Biol 31:1066-1075.
2. Barnes WG, Reiter E, Violin JD, Ren XR, Milligan G, and Lefkowitz RJ (2005) beta-Arrestin 1 and Galphaq/11 coordinately activate RhoA and stress fiber formation following receptor stimulation. J Biol Chem 280:8041-8050. (Pubitemid 40349702)
3. Beaulieu JM, Sotnikova TD, Marion S, Lefkowitz RJ, Gainetdinov RR, and Caron MG (2005) An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell 122:261-273. (Pubitemid 41032989)
4. Bhattacharya M, Anborgh PH, Babwah AV, Dale LB, Dobransky T, Benovic JL, Feldman RD, Verdi JM, Rylett RJ, And Ferguson SS (2002) Beta-arrestins regulate a Ral-GDS Ral effector pathway that mediates cytoskeletal reorganization. Nat Cell Biol 4:547-555.
5. Bhattacharya M, Wang J, Ribeiro FM, Dixon SJ, Feldman RD, Hegele RA, and Ferguson SS (2007) Analysis of a missense variant of the human N-formyl peptide receptor that is associated with agonist-independent beta-arrestin association and indices of inflammation. Pharmacogenomics J 7:190-199. (Pubitemid 46785160)
6. Bouschet T, Martin S, Kanamarlapudi V, Mundell S, and Henley JM (2007) The calcium-sensing receptor changes cell shape via a beta-arrestin-1 ARNO ARF6 ELMO protein network. J Cell Sci 120:2489-2497. (Pubitemid 47323858)
7. Campellone KG and Welch MD (2010) A nucleator arms race: cellular control of actin assembly. Nat Rev Mol Cell Biol 11:237-251.
8. Cantley LC (2002) The phosphoinositide 3-kinase pathway. Science 296:1655-1657.
9. Cenac N, Chin AC, Garcia-Villar R, Salvador-Cartier C, Ferrier L, Vergnolle N, Buret AG, Fioramonti J, and Bueno L (2004) PAR2 activation alters colonic paracellular permeability in mice via IFN-gamma-dependent and -independent pathways. J Physiol 558:913-925. (Pubitemid 39199112)
10. Cheung R, Malik M, Ravyn V, Tomkowicz B, Ptasznik A, and Collman RG (2009) An arrestin-dependent multi-kinase signaling complex mediates MIP-1beta/CCL4 signaling and chemotaxis of primary human macrophages. J Leukoc Biol 86:833-845.
11. Cho EY, Cho DI, Park JH, Kurose H, Caron MG, and Kim KM (2007) Roles of protein kinase C and actin-binding protein 280 in the regulation of intracellular trafficking of dopamine D3 receptor. Mol Endocrinol 21:2242-2254. (Pubitemid 47347385)
12. Christensen GL, Kelstrup CD, Lyngsø C, Sarwar U, Bøgebo R, Sheikh SP, Gammeltoft S, Olsen JV, and Hansen JL (2010) Quantitative phosphoproteomics dissection of seven-transmembrane receptor signaling using full and biased agonists. Mol Cell Proteomics 9:1540-1553.
13. Claing A, Chen W, Miller WE, Vitale N, Moss J, Premont RT, and Lefkowitz RJ (2001) β-Arrestin-mediated ADP-ribosylation factor 6 activation and beta 2-adrenergic receptor endocytosis. J Biol Chem 276:42509-42513.
14. Cotton M and Claing A (2009) G protein-coupled receptors stimulation and the control of cell migration. Cell Signal 21:1045-1053.
15. DeFea K (2008) Beta-arrestins and heterotrimeric G-proteins: collaborators and competitors in signal transduction. Br J Pharmacol 153 (Suppl 1):S298-S309.
16. DeFea KA (2007) Stop that cell! Beta-arrestin-dependent chemotaxis: a tale of localized actin assembly and receptor desensitization. Annu Rev Physiol 69:535-560.
17. DeFea KA (2011) Beta-arrestins as regulators of signal termination and transduction: how do they determine what to scaffold? Cell Signal 23:621-629.
18. DeFea KA, Vaughn ZD, O'Bryan EM, Nishijima D, Déry O, and Bunnett NW (2000a) The proliferative and antiapoptotic effects of substance P are facilitated by formation of a beta -arrestin-dependent scaffolding complex. Proc Natl Acad Sci USA 97:11086-11091.
19. DeFea KA, Zalevsky J, Thoma MS, Déry O, Mullins RD, and Bunnett NW (2000b) beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2. J Cell Biol 148:1267-1281.
20. DeWire SM, Ahn S, Lefkowitz RJ, and Shenoy SK (2007) Beta-arrestins and cell signaling. Annu Rev Physiol 69:483-510.
21. Dickey BF, Walker JK, Hanania NA, and Bond RA (2010) Beta-adrenoceptor inverse agonists in asthma. Curr Opin Pharmacol 10:254-259.
22. Eutamene H, Theodorou V, Schmidlin F, Tondereau V, Garcia-Villar R, Salvador-Cartier C, Chovet M, Bertrand C, and Bueno L (2005) LPS-induced lung inflammation is linked to increased epithelial permeability: role of MLCK. Eur Respir J 25:789-796. (Pubitemid 40667675)
23. Firat-Karalar EN and Welch MD (2011) New mechanisms and functions of actin nucleation. Curr Opin Cell Biol 23:4-13.
24. Fong AM, Premont RT, Richardson RM, Yu YR, Lefkowitz RJ, and Patel DD (2002) Defective lymphocyte chemotaxis in beta-arrestin2- and GRK6-deficient mice. Proc Natl Acad Sci USA 99:7478-7483. (Pubitemid 34568716)
25. Ge L, Ly Y, Hollenberg M, and DeFea K (2003) A beta-arrestin-dependent scaffold is associated with prolonged MAPK activation in pseudopodia during protease-activated receptor-2-induced chemotaxis. J Biol Chem 278:34418-34426. (Pubitemid 37553288)
26. Ge L, Shenoy SK, Lefkowitz RJ, and DeFea K (2004) Constitutive protease-activated receptor-2-mediated migration of MDA MB-231 breast cancer cells requires both beta-arrestin-1 and -2. J Biol Chem 279:55419-55424. (Pubitemid 40066542)
27. Gong K, Li Z, Xu M, Du J, Lv Z, and Zhang Y (2008) A novel protein kinase A-independent, beta-arrestin-1-dependent signaling pathway for p38 mitogen-activated protein kinase activation by beta2-adrenergic receptors. J Biol Chem 283:29028-29036.
28. Hall A (1998) Rho GTPases and the actin cytoskeleton. Science 279:509-514.
29. Han MY, Kosako H, Watanabe T, and Hattori S (2007) Extracellular signal-regulated kinase/mitogen-activated protein kinase regulates actin organization and cell motility by phosphorylating the actin cross-linking protein EPLIN. Mol Cell Biol 27:8190-8204. (Pubitemid 350234233)
30. He HJ, Kole S, Kwon YK, Crow MT, and Bernier M (2003) Interaction of filamin A with the insulin receptor alters insulin-dependent activation of the mitogen-activated protein kinase pathway. J Biol Chem 278:27096-27104. (Pubitemid 36876864)
31. Hunton DL, Barnes WG, Kim J, Ren XR, Violin JD, Reiter E, Milligan G, Patel DD, and Lefkowitz RJ (2005a) β-arrestin 2-dependent angiotensin II type 1A receptor-mediated pathway of chemotaxis. Mol Pharmacol 67:1229-1236. (Pubitemid 40410423)
32. Hunton DL, Barnes WG, Kim J, Ren XR, Violin JD, Reiter E, Milligan G, Patel DD, and Lefkowitz RJ (2005b) Beta-arrestin 2-dependent angiotensin II type 1A receptor-mediated pathway of chemotaxis. Mol Pharmacol 67:1229-1236. (Pubitemid 40410423)
33. Huveneers S and Danen EH (2009) Adhesion signaling - crosstalk between integrins, Src and Rho. J Cell Sci 122:1059-1069.
34. Jacob C, Yang PC, Darmoul D, Amadesi S, Saito T, Cottrell GS, Coelho AM, Singh P, Grady EF, Perdue M, et al. (2005) Mast cell tryptase controls paracellular permeability of the intestine. Role of protease-activated receptor 2 and beta-arrestins. J Biol Chem 280:31936-31948. (Pubitemid 41291944)
35. Jog NR, Jala VR, Ward RA, Rane MJ, Haribabu B, and McLeish KR (2007) Heat shock protein 27 regulates neutrophil chemotaxis and exocytosis through two independent mechanisms. J Immunol 178:2421-2428. (Pubitemid 46233442)
36. 8]angiotensin II regulates a robust G protein-independent signaling network. J Biol Chem 286:19880-19891.
37. Kim H and McCulloch CA (2011) Filamin A mediates interactions between cytoskeletal proteins that control cell adhesion. FEBS Lett 585:18-22.
38. Kim JI, Lakshmikanthan V, Frilot N, and Daaka Y (2010) Prostaglandin E2 promotes lung cancer cell migration via EP4-βArrestin1-c-Src signalsome. Mol Cancer Res 8:569-577.
39. Kim KM, Gainetdinov RR, Laporte SA, Caron MG, and Barak LS (2005) G protein-coupled receptor kinase regulates dopamine D3 receptor signaling by modulating the stability of a receptor-filamin-beta-arrestin complex. A case of autoreceptor regulation. J Biol Chem 280:12774-12780.
40. Klemke RL, Cai S, Giannini AL, Gallagher PJ, de Lanerolle P, and Cheresh DA (1997) Regulation of cell motility by mitogen-activated protein kinase. J Cell Biol 137:481-492. (Pubitemid 27181299)
41. Lagane B, Chow KY, Balabanian K, Levoye A, Harriague J, Planchenault T, Baleux F, Gunera-Saad N, Arenzana-Seisdedos F, and Bachelerie F (2008) CXCR4 dimerization and beta-arrestin-mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome. Blood 112:34-44.
42. Li TT, Alemayehu M, Aziziyeh AI, Pape C, Pampillo M, Postovit LM, Mills GB, Babwah AV, and Bhattacharya M (2009) Beta-arrestin/Ral signaling regulates lysophosphatidic acid-mediated migration and invasion of human breast tumor cells. Mol Cancer Res 7:1064-1077.
43. Luttrell LM and Gesty-Palmer D (2010) Beyond desensitization: physiological relevance of arrestin-dependent signaling. Pharmacol Rev 62:305-330.
44. Mendoza MC, Er EE, Zhang W, Ballif BA, Elliott HL, Danuser G, and Blenis J (2011) ERK-MAPK drives lamellipodia protrusion by activating the WAVE2 regulatory complex. Mol Cell 41:661-671.
45. Mukherjee S, Gurevich VV, Jones JC, Casanova JE, Frank SR, Maizels ET, Bader MF, Kahn RA, Palczewski K, Aktories K, et al. (2000) The ADP ribosylation factor nucleotide exchange factor ARNO promotes beta-arrestin release necessary for luteinizing hormone/choriogonadotropin receptor desensitization. Proc Natl Acad Sci USA 97:5901-5906. (Pubitemid 30367496)
46. Mythreye K and Blobe GC (2009a) The type III TGFbeta receptor regulates directional migration: new tricks for an old dog. Cell Cycle 8:3069-3070.
47. Mythreye K and Blobe GC (2009b) The type III TGF-beta receptor regulates epithelial and cancer cell migration through beta-arrestin2-mediated activation of Cdc42. Proc Natl Acad Sci USA 106:8221-8226.
48. Naga Prasad SV, Laporte SA, Chamberlain D, Caron MG, Barak L, and Rockman HA (2002) Phosphoinositide 3-kinase regulates beta2-adrenergic receptor endocytosis by AP-2 recruitment to the receptor/beta-arrestin complex. J Cell Biol 158:563-575. (Pubitemid 34851714)
49. Nakagawa K, Sugahara M, Yamasaki T, Kajiho H, Takahashi S, Hirayama J, Minami Y, Ohta Y, Watanabe T, Hata Y, et al. (2010) Filamin associates with stress signalling kinases MKK7 and MKK4 and regulates JNK activation. Biochem J 427:237-245.
50. Nakanishi O, Suetsugu S, Yamazaki D, and Takenawa T (2007) Effect of WAVE2 phosphorylation on activation of the Arp2/3 complex. J Biochem 141:319-325. (Pubitemid 46770384)
51. Nelson CD, Kovacs JJ, Nobles KN, Whalen EJ, and Lefkowitz RJ (2008) β-arrestin scaffolding of phosphatidylinositol 4-phosphate 5-kinase Iα promotes agonist-stimulated sequestration of the β2-adrenergic receptor. J Biol Chem 283:21093-21101.
52. Nienaber JJ, Tachibana H, Naga Prasad SV, Esposito G, Wu D, Mao L, and Rockman HA (2003) Inhibition of receptor-localized PI3K preserves cardiac beta-adrenergic receptor function and ameliorates pressure overload heart failure. J Clin Invest 112:1067-1079. (Pubitemid 38056322)
53. Ohta Y, Suzuki N, Nakamura S, Hartwig JH, and Stossel TP (1999) The small GTPase RalA targets filamin to induce filopodia. Proc Natl Acad Sci USA 96:2122-2128.
54. Okreglak V and Drubin DG (2007) Cofilin recruitment and function during actin-mediated endocytosis dictated by actin nucleotide state. J Cell Biol 178:1251-1264. (Pubitemid 47480230)
55. Pichon S, Bryckaert M, and Berrou E (2004) Control of actin dynamics by p38 MAP kinase - Hsp27 distribution in the lamellipodium of smooth muscle cells. J Cell Sci 117:2569-2577. (Pubitemid 38877852)
56. Povsic TJ, Kohout TA, and Lefkowitz RJ (2003) β-Arrestin1 mediates insulin-like growth factor 1 (IGF-1) activation of phosphatidylinositol 3-kinase (PI3K) and anti-apoptosis. J Biol Chem 278:51334-51339. (Pubitemid 38020372)
57. Rojanathammanee L, Harmon EB, Grisanti LA, Govitrapong P, Ebadi M, Grove BD, Miyagi M, and Porter JE (2009) The 27-kDa heat shock protein confers cytoprotective effects through a β2-adrenergic receptor agonist-initiated complex with β-arrestin. Mol Pharmacol 75:855-865.
58. Scott MG, Pierotti V, Storez H, Lindberg E, Thuret A, Muntaner O, Labbé-Jullié C, Pitcher JA, and Marullo S (2006) Cooperative regulation of extracellular signal-regulated kinase activation and cell shape change by filamin A and beta-arrestins. Mol Cell Biol 26:3432-3445.
59. Sun Y, Cheng Z, Ma L, and Pei G (2002) β-arrestin2 is critically involved in CXCR4-mediated chemotaxis, and this is mediated by its enhancement of p38 MAPK activation. J Biol Chem 277:49212-49219. (Pubitemid 36014350)
60. Velculescu VE, Zhang L, Vogelstein B, and Kinzler KW (1995) Serial analysis of gene expression. Science 270:484-487.
61. Walker JK, Fong AM, Lawson BL, Savov JD, Patel DD, Schwartz DA, and Lefkowitz RJ (2003) Beta-arrestin-2 regulates the development of allergic asthma. J Clin Invest 112:566-574. (Pubitemid 38056341)
62. Wang P and DeFea KA (2006) Protease-activated receptor-2 simultaneously directs beta-arrestin-1-dependent inhibition and Galphaq-dependent activation of phosphatidylinositol 3-kinase. Biochemistry 45:9374-9385. (Pubitemid 44223242)
63. Wang P, Kumar P, Wang C, and Defea KA (2007) Differential regulation of class IA phosphoinositide 3-kinase catalytic subunits p110 alpha and beta by protease-activated receptor 2 and beta-arrestins. Biochem J 408:221-230. (Pubitemid 350206345)
64. Xiao K, McClatchy DB, Shukla AK, Zhao Y, Chen M, Shenoy SK, Yates JR 3rd, and Lefkowitz RJ (2007) Functional specialization of beta-arrestin interactions revealed by proteomic analysis. Proc Natl Acad Sci USA 104:12011-12016. (Pubitemid 47185621)
65. Xiao K, Sun J, Kim J, Rajagopal S, Zhai B, Villén J, Haas W, Kovacs JJ, Shukla AK, Hara MR, et al. (2010) Global phosphorylation analysis of beta-arrestin-mediated signaling downstream of a seven transmembrane receptor (7TMR). Proc Natl Acad Sci USA 107:15299-15304.
66. 2+signaling to RhoA. Arterioscler Thromb Vasc Biol 29:1657-1663.
67. Zoudilova M, Kumar P, Ge L, Wang P, Bokoch GM, and DeFea KA (2007) Beta-arrestin-dependent regulation of the cofilin pathway downstream of protease-activated receptor-2. J Biol Chem 282:20634-20646. (Pubitemid 47100047)
68. Zoudilova M, Min J, Richards HL, Carter D, Huang T, and DeFea KA (2010) β-arrestins scaffold cofilin with chronophin to direct localized actin filament severing and membrane protrusions downstream of protease-activated receptor-2. J Biol Chem 285:14318-14329.